SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed on August 15, 2023, by Ra Medical Systems, Inc. (not Catheter Precision, Inc., as noted in the metadata request). The filing addresses a delay in the submission of the Company's Quarterly Report on Form 10-Q for the period ended June 30, 2023. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing provides preliminary revenue estimates rather than finalized financial statements. No data regarding profit, cash flow, margins, debt, or liquidity is included in this specific report.
- Estimated Revenue (Q2 2023): Approximately $96,000 for the quarter ended June 30, 2023.
- Estimated Revenue (YTD 2023): Approximately $181,000 for the six months ended June 30, 2023.
Material Changes and Unusual Items
The primary material event is the filing of a Form 12b-25, indicating the Company will be late in filing its required 10-Q. The revenue figures provided are preliminary and subject to adjustment based on the final review by the Company's auditors. No other material changes to operations or financial condition are detailed in this text.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance or management commentary beyond the preliminary revenue estimates. The primary risk highlighted is the uncertainty of the final financial numbers, which may differ from the estimates due to the ongoing audit review process.
Investor Verification Checklist
- Verify the final audited revenue figures for the quarter and six months ended June 30, 2023, once the Form 10-Q is filed.
- Confirm the reasons for the delay in the 10-Q filing as detailed in the subsequent Form 12b-25 or the final 10-Q.
- Review the final 10-Q for complete data on profitability, cash flow, and liquidity, which are absent in this 8-K.